Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126203261 | 12620326 | 1 | I | 20160729 | 20160803 | 20160803 | EXP | PHHY2016VE106634 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160804 | CN | VE | VE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126203261 | 12620326 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Unknown | 400 MG, QD | 16608 | 400 | MG | QD | |||||||
126203261 | 12620326 | 2 | SS | TEGRETOL | CARBAMAZEPINE | 1 | Unknown | 200 MG, QD (STRENGTH: 200 MG) | 16608 | 200 | MG | QD | |||||||
126203261 | 12620326 | 3 | SS | TOPIRAMATE. | TOPIRAMATE | 1 | Unknown | 200 MG, QD | U | 0 | 200 | MG | QD | ||||||
126203261 | 12620326 | 4 | C | VALCOTE | VALPROATE SODIUM | 1 | Unknown | UNK UNK, QD | U | 0 | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126203261 | 12620326 | 1 | Brain neoplasm |
126203261 | 12620326 | 3 | Brain neoplasm |
126203261 | 12620326 | 4 | Brain neoplasm |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126203261 | 12620326 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126203261 | 12620326 | Product use issue | |
126203261 | 12620326 | Reduced facial expression | |
126203261 | 12620326 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |